As helicase–nuclease–RPA complexes can enable transcription and replication stress in cancer cells with impacts on tumor survival and genome instability, they may provide drug targets with the potential to be less pleiotropic than current kinase targets in the clinic. The gene discussed is RPA1; the disease is neoplasm.